Startseite Naturwissenschaften Crystal structure of 2,8-diphenyl-3,7,9-trioxa-1-azaspiro[4.5]dec-1-ene, C18H17N1O3
Artikel Open Access

Crystal structure of 2,8-diphenyl-3,7,9-trioxa-1-azaspiro[4.5]dec-1-ene, C18H17N1O3

  • Min Zhang , Zhong-Yan Li , Xian-You Yuan und Lin Yuan EMAIL logo
Veröffentlicht/Copyright: 16. Oktober 2017

Abstract

C18H17N1O3, monoclinic, P21/c (no. 14), a = 14.9752(8) Å, b = 9.0793(5) Å, c = 11.1030(6) Å, β = 106.431(1)°, V = 1447.96(14) Å3, Z = 4, Rgt(F) = 0.0342, wRref(F2) = 0.0903, T = 296(2) K.

CCDC no.:: 1577299

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Block, colorless
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.09 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω-scans
2θmax, completeness:25°, >99%
N(hkl)measured, N(hkl)unique, Rint:26710, 2541, 0.018
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2384
N(param)refined:199
Programs:Bruker programs [1], SHELX [2, 3]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O30.06061(6)0.17715(10)0.24804(7)0.0270(2)
O20.07766(6)0.35823(9)0.10810(7)0.0275(2)
O1−0.21461(6)0.32501(10)0.03002(9)0.0349(2)
N1−0.13695(7)0.14691(11)−0.04115(9)0.0265(2)
C1−0.06661(8)0.21939(13)0.06214(11)0.0256(3)
C50.12246(8)0.24476(13)0.19006(11)0.0233(3)
H50.14560.17060.14210.028*
C13−0.30284(8)0.18096(13)−0.14404(11)0.0261(3)
C12−0.21330(9)0.21354(14)−0.05101(11)0.0276(3)
C4−0.01397(8)0.10583(14)0.15649(11)0.0278(3)
H4A−0.05590.05970.19760.033*
H4B0.01090.02990.11360.033*
C70.23114(9)0.24366(15)0.40891(12)0.0295(3)
H70.19740.16530.42770.035*
C60.20345(8)0.30765(13)0.29031(11)0.0247(3)
C18−0.30567(9)0.07887(14)−0.23862(11)0.0282(3)
H18−0.25100.0349−0.24450.034*
C14−0.38491(9)0.24658(15)−0.13635(13)0.0337(3)
H14−0.38350.3151−0.07360.040*
C30.00384(9)0.29752(14)0.00848(11)0.0273(3)
H3A0.02930.2282−0.03950.033*
H3B−0.02690.3757−0.04760.033*
C80.30866(9)0.29594(16)0.49914(12)0.0338(3)
H80.32650.25260.57820.041*
C110.25427(9)0.42562(15)0.26460(12)0.0340(3)
H110.23630.47020.18600.041*
C15−0.46869(9)0.20986(16)−0.22206(14)0.0404(3)
H15−0.52360.2539−0.21690.049*
C2−0.12262(9)0.32762(17)0.11823(13)0.0373(3)
H2A−0.12450.29570.20080.045*
H2B−0.09600.42570.12480.045*
C17−0.38951(9)0.04279(16)−0.32366(13)0.0353(3)
H17−0.3912−0.0255−0.38670.042*
C100.33164(10)0.47703(17)0.35560(14)0.0412(3)
H100.36510.55630.33780.049*
C90.35948(9)0.41159(16)0.47264(13)0.0374(3)
H90.41210.44540.53300.045*
C16−0.47099(9)0.10798(17)−0.31533(14)0.0410(4)
H16−0.52740.0832−0.37260.049*

Source of material

Tris(hydroxymethyl)aminomethane (TRIS) (2.00 g, 16.5 mmol) and benzaldehyde (5.31 g, 50 mmol) were stirred at 338 K in anhydrous toluene (50 mL) until the reaction mixture becomes clear. The solvent was evaporated to dryness and the residue dissolved in diethylether (50 mL). The etheral solution was washed with a saturated Na2CO3 solution (10 mL). The aqueous phase was extracted with diethylether and the combined organic phase was dried over anhydrous Na2SO4, then evaporated to a white powder. The latter was recrystallized from ethanol to afford colorless crystals (2.73 g, 56%).

Experimental details

All hydrogen atoms were identified in difference Fourier syntheses.

Discussion

Synthetic routes employing oxazolidines as cyclic protection of aminoalcohols have been widely used for the asymmetric synthesis of chiral amines, aminoalcohols and/or aminoacids [4]. Moreover, such derivatives were assumed to have potential as prodrug forms, as they undergo conversion to the parent compound [5]. Indeed, oxazolidine derived from ephedrine has been proved to have sympathomimetic activity in several animal models [6, 7] . In both cases, the success of the approach relies on the cleavage of the 1,3-N,O ring.

Herein, we report on a new oxazolidine derivative, which was synthesized and characterized by single-crystal X-ray diffraction [2, 3] . In the structure, there are two new formed rings, C(1)—C(3)—O(2)—C(5)—O(3)—C(4) and C(1)—N(1)—C(12)—O(1)—C(2). The bond lengths of N(1)—C(1), N(1)—C(12) are 1.4746(15) Å and 1.2706(16) Å respectively. All geometric parameters are in the expected ranges [8, 9] .

Acknowledgement

This work was financially supported by the Scientific Research Fund of Hunan Provincial Education Department (No. 16B104), the Opening Project of Key Laboratory of Comprehensive Utilization of Advantage Plants Resources in Hunan South (No. XNZW16C01) and the Scientific Research Fund of Hunan University of Science and Engineering (No. 16XKY063), Natural Science Foundation of Hunan Province of China (2017JJ3093).

References

Bruker. APEX2, SAINT and SADABS. Brucker AXS Inc., Madison, Wisconsin, USA, (2009).Suche in Google Scholar

Sheldrick, G. M.: SHELXS-97: Program for the Solution of Crystal Structures. University of Göttingen, Germany, (1997).Suche in Google Scholar

Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar

Wagner, B.; Gonzalez, G. I.; Tran Hun Dau, M. E.; Zhu, J.: Total synthesis and conformational studies of hapalosin, N-desmethylhapalosin and 8-deoxyhapalosin. Bioorg. Med. Chem. 7 (1999) 737–C747.10.1016/S0968-0896(98)00208-9Suche in Google Scholar

Berrien, J. F.; Royer, J.; Husson, H. P.: A new access to enantiomerically pure (S)-(-)-pipecolic acid and 2-alkylated or 6-alkylated derivatives. J. Org. Chem. 59 (1994) 3769–C3774.10.1021/jo00093a007Suche in Google Scholar

Johansen, M.; Bundgaard, H.: Hydrolysis of oxazolidines – a potential new prodrug type. J. Pharm. Sci. 72 (1983) 1294–C1298.10.1002/jps.2600721115Suche in Google Scholar

Walker, R. B.; Huang, M. J.; Leszczynski, J.: An investigation of isomeric differences in hydrolytic rates of oxazolidines using computational methods. J. Mol. Struct. 549 (2001) 137–C146.10.1016/S0166-1280(01)00489-4Suche in Google Scholar

Jia, G.-K.; Yuan, L.; Yuan, X.-Y.; Li, Z.-Y.: Crystal structure of 5-ethyl-2-(p-tolyl)-1,3-dioxane-5-carboxylic acid, C14H18O4. Z. Kristallogr. NCS 232 (2017) 819–820.10.1515/ncrs-2017-0061Suche in Google Scholar

Jia, G.-K.; Yuan, L.; Zhang, M., Yuan, X.-Y.; Liu, F.: Crystal structure of 2-(2-bromophenyl)-5-methyl-1,3-dioxane-5-carboxylic acid, C12H13BrO4. Z. Kristallogr. NCS 231 (2016) 1207–1208.10.1515/ncrs-2016-0135Suche in Google Scholar

Received: 2017-6-22
Accepted: 2017-9-29
Published Online: 2017-10-16
Published in Print: 2017-11-27

©2017 Min Zhang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of potassium 1-methyl-1H-1,2,3,4-tetrazole-5-thiolate, C2H3N4SK
  3. Crystal structure of bis(3-(3-ethylureido)-N,N-dimethylpropan-1-aminium) bis (μ3-2-(hydroxymethyl)-2-(oxidomethyl)propane-1,3-bis(olato))-(μ6-oxo)-hexakis(μ2-oxo)-hexaoxo-hexavanadium(V) – dichloromethane (1/1), C27H60Cl2N6O23V6
  4. Crystal structure of bis(μ3-methanolato-κ3O:O:O)-bis(μ2-methanolato-κ2O:O)-dimethanol-bis{6,6′-(1,3-dihydroxyl-2-acetylpropane-1,3-diyl)bis(2-chloro-4-bromophenolato)}tetramanganese(III) C40H40Br4Cl4Mn4O16
  5. Synthesis and crystal structure of tetrakis(μ2-methanolato)-dimethanol-bis(μ2-2-acetyl-1,3-bis(3,5-dibromo-2-oxidophenyl)propane-1,3-bis(olato)-κ5O1,O2,O3:O3,O4,O5)tetramanganese(III), C40H40Br8Mn4O16
  6. Synthesis and crystal structure tetrakis(μ2-methanolato)-dimethanol-bis(μ2-2-acetyl-1,3-bis(3,5-dichloro-2-oxidophenyl)propane-1,3-bis(olato)-κ5O1,O2,O3:O3,O4,O5), tetramanganese(III), C40H40Cl8Mn4O16
  7. Crystal structure of bis{5-methoxy-2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O)}copper(II), C34H34CuN4O6
  8. Crystal structure of (E)-1-(2-hydroxy-3-{[2-hydroxybenzylidene]amino}phenyl)ethan-1-one, C15H13NO3
  9. Crystal structure of bis(μ2-acetato-κ2O:O′)-bis{μ2-4-chloro-2-(8-(4-(diethylamino)-2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenolato-κ6O:O,N,N′,O′′:O′′}tricobalt(II), C44H49Cl2Co3N6O12
  10. Crystal structure of bis{μ2-2,4-dichloro-6-(8-(4-(diethylamino)-2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenolato-κ5O:O,N,N′,O′}dicobalt(II) acetone solvate, C43H48Br4Co2N6O9
  11. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)-bis{μ2-4-chloro-2-(8-(4-(diethylamino)-2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenolato-κ6O:O,N,N′,O′:O′}trizinc(II), C44H49Cl2N6O12Zn3
  12. Crystal structure of bis{5-(N,N′-diethylamine)-5′-methoxy -2,2′-[ethylenediyldioxybis(nitrilomethylidyne)]diphenolato}-bis(μ2-acetato-κ2O:O′)trizinc(II), C46H56Zn3N6O14
  13. Crystal structure of tris(cyano-(hydrogen tris(3,5-dimethylpyrazolyl)borate))-iron(III) 4-methoxypyridinium monohydrate, C24H32BN10O2Fe
  14. Synthesis and crystal structure of bis{1-(((4-(1-(hydroxyimino)ethyl)phenyl)imino)methyl)naphthalen-2-olato-κ2O,N}copper(II), C38H30CuN4O4
  15. Crystal structure of (E)-1-(4-{[(E)-2-Hydroxy-1-naphthalenylmethylene] amino}phenyl)ethanone oxime, C19H16N2O2
  16. The pseudosymmetric crystal structure of 2-(2-naphthalenyl)-3-nitro-2H-1-benzopyran, C38H26N2O6
  17. Crystal structure of 2-benzoyl-3-(4-methoxyphenyl)cyclopropane-1,1-dicarbonitrile, C19H14N2O2
  18. N′-(5-ethoxycarbonyl-3,4-dimethyl-pyrrol-2-yl-methylidene)-4-hydroxybenzohydrazide monohydrate, C17H21N3O5
  19. The crystal structure of carbonyl-[4-(2,4-dichlorophenylamino)pent-3-en-2-onato-κ2N,O]-(triphenylphosphine-κP)rhodium(I), RhC30H25Cl2NO2P
  20. Crystal structure of (E)-5-(diethylamino)-2-(((1,1,2-trihydroxyethyl)iminio)methyl)phenolate, C15H24N2O4
  21. Crystal structure of poly[(μ2-1,4-bis((2-ethyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)(μ2-isophthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C34H30N4O4Cd
  22. Crystal structure of 5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]chinolizinium 3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate - methanol - water (1/1/1), C36H33NO10
  23. A single crystal study on 2-(methylcarbamoyl)benzoic acid, C9H9NO3
  24. Crystal structure of the salt 1,1′-(ethane-1,2-diyl)bis(1,4-diazabicyclo[2.2.2]octan-1-ium) diperchlorate, C14H28N4(ClO4)2
  25. Crystal structure of 2,5-bis((E)-2-(trifluoromethyl)benzylidene)cyclopentan-1-one, C21H14F6O
  26. Crystal structure of catena-poly[(μ2-benzene-1,4-dicarboxylato-κ2O:O′)-(1-ethyl-6-fluoro-7-(4-methylpiperazin-1-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylato-κ2O,O′)zinc(II)] 1.25 hydrate, C25H26.5N3O8.25FZn
  27. Crystal structure of 1-methyl-1,4-diazabicyclo[2.2.2]octan-1-ium poly[aqua-bis(μ2-perchlorato-κ3O,O′:O′′)sodium], C7H17Cl2N2NaO9
  28. Crystal structure of trimethyammonium 2,6-dicarboxyisonicotinate monohydrate, C11H16N2O7
  29. Crystal structure of dodecaguanidinium bis(tetrapropylammonium) heptacarbonate, C43H128N38O21
  30. Crystal structure of poly[tetraaqua-bis(μ6-benzene-1,2,4,5-tetracarboxylato)nickel(II)diyttrium(III)]dihydrate, C20H16NiO22Y2
  31. Halogen bonds and π–π interactions in the crystal structure of 1,3,5-trifluoro-2,4,6-triiodobenzene–N,N-dimethylformamide (1/1), C9H7F3I3NO
  32. Crystal structure of guanidinium tetraethylammonium carbonate dihydrate, C10H30N4O5
  33. The crystal structure of oxonium chlorido-ethylenediaminetetraactetotin(IV) hydrate, C10H17ClN2O10Sn
  34. Crystal structure of 8-((E)-((4-((E)-1-((benzyloxy)imino)ethyl)phenyl)imino)methyl)-7-hydroxy-4-methyl-2H-chromen-2-one, C26H22N2O4
  35. Crystal structure of bis{5-(diethylamino)-2-(((2-oxo-2H-chromen-6-yl)imino)methyl)phenolato-κ2O,N}copper(II), C40H38CuN4O6
  36. Crystal structure of fac-(acetylacetonato-κ2O,O′)tricarbonyl(tri(p-tolyl)phosphine-κP)rhenium(I), C29H28O5PRe
  37. Crystal structure of fac-(acetylacetonato-κ2O,O′)tricarbonyl(benzyldiphenylphosphine-κP)rhenium(I), C27H24O5PRe
  38. Crystal structure of triethylammonium bis{3-(((3-oxidonaphthalen-1-yl)methylene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}manganese(III), C46H38MnN3O8
  39. Crystal structure of bis(N,N,N-ethyldimethylethanaminium) bis(heptaselenido-κ2Se1,Se7)palladate(II), C12H32N2PdSe14
  40. Crystal structure of bis(4-(1H-pyrazol-5-yl)pyridine-κ2N:N′)-bis(2-(2-((2,6-difluorophenyl)amino)phenyl)acetate-κO)cadmium(II), C44H34N8CdCl4O4
  41. Crystal structure of 4,4′-(1,4-phenylene)bis(pyridin-1-ium) catena-poly[diaqua-bis(μ2-3′,5′-dicarboxy-[1,1′-biphenyl]-2,5-dicarboxylato-κ2O:O′] dihydrate, C48H42O22N2Ca
  42. The crystal structure of (S)-2-benzylsuccinic acid, C11H12O4
  43. Crystal structure of poly[aqua-(μ3-4-(pyridin-4-yl)isophthalato-κ4O,O′:O′′:O′′′)-(μ2-5-carboxy-2-(pyridin-4-yl)benzoato-κ2O:O′)yttrium(III)], C26H17N2O9Y
  44. Crystal structure of ethyl 1-(3,4-dimethylphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylate, C14H17N3O2
  45. Crystal structure of tetrakis(methanol-κO)-bis{μ2-3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olate-κ4O,N;O′:O′}dizinc(II), C38H38Zn2N2O14
  46. Crystal structure of bromido(4,4′-dimethoxy-2,2′-bipyridine-κ2N,N′)(isopropyl(diphenyl)phosphane-κP)copper(I), C27H29BrCuN2O2P
  47. Crystal structure of bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)-9,9-dioctylfluorene, C41H64B2O4
  48. Crystal structure of 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carbaldehyde - a julolidine derivative, C16H15NO3
  49. Crystal structure of 1,3-dimethyl-5,5-dibenzylbarbituric acid, C20H20N2O3
  50. Crystal structure of bis(N,N,N-trimethylethanaminium) poly[bis(μ2-heptaselenido-κ2Se1,Se7)palladate(II)], C10H28N2PdSe14
  51. Crystal structure of 1-{4-[(5-Chloro-2-hydroxy-benzylidene)amino]phenyl} ethanone O-ethyl-oxime, C17H17ClN2O2
  52. The crystal structure of methyl N-(4-bromophenyl)carbamate, C8H8BrNO2
  53. Synthesis and crystal structure of 1-{4-[(2-hydroxy-benzylidene)amino]phenyl}ethanone oxime, C15H14N2O2
  54. Crystal structure of 1,1′-butanebis(3-methyl-1H-imidazol-3-ium)bis(hexafluorophosphate), C12H20F12N4P2
  55. (E)-N-benzylidene-3-(benzylthio)-5-p-tolyl-4H-1,2,4-triazol-4-amine, C23H20N4S
  56. Crystal structure of ethyl 5-methyl-1-(pyridin-3-yl)-1H-1,2,3-triazole-4-carboxylate, C11H12N4O2
  57. Crystal structure of 5,5-difluoro-10-(4-fluorophenyl)-1,3,7,9-tetramethyl-5H-4l4,5l4-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine - a Z′ = 3 structure, C19H18B2F3N2
  58. The crystal structure of the Matrine derivative: 12-(1H-indol-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one hydrate, C23H29N3O
  59. The crystal structure of tris(μ2-1,3-bis(4,4,4-trifluoro-3-oxido-1-(oxo)but-2-en-1-yl)phenyl-κ4O,O′:O′′,O′′′)-bis(1,2-dimethoxyethane-κ2O,O′)dilutetium(III), C50H38F18Lu2O16
  60. The crystal structure of (Z)-2-(3-(2-(4-chlorobenzoyl)hydrazono)-2-oxoindolin-1-yl) acetic acid, C17H12ClN3O4
  61. Synthesis and crystal structure of trans-tetraqua-bis(2-(((7-hydroxy-3-(4-hydroxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)ammonio)acetato-κO)cobalt(II) hexahydrate, C36H48CoN2O28S2
  62. The crystal structure of N,N-dimethyl-2,6-di-p-tolylpyrimidin-4-amine, C20H21N3
  63. The crystal structure (E)-4-methyl-N′-(2-nitrobenzylidene)benzenesulfonohydrazide, C14H13N3O4S
  64. Crystal structure of catena-poly[(μ2-1,3-bis(benzimidazol-1-yl)propane κ2N:N′)-(μ2-5-methoxyisophthalato-κ2O:O′)zinc(II)] hydrate, C26H24ZnN4O6
  65. The crystal structure of (E)-N′-(quinolin-2-ylmethylene)furan-2-carbohydrazide monohydrate, C15H13N3O3
  66. Crystal structure of 2,8-diphenyl-3,7,9-trioxa-1-azaspiro[4.5]dec-1-ene, C18H17N1O3
  67. Crystal structure of diethyl 2-(4-chlorophenyl)-1,3-dioxane-5,5-dicarboxylate, C16H19ClO6
  68. Crystal structure of 1-(carboxymethyl)-1H-benzo[d][1,2,3]triazole 3-oxide, C8H7N3O3
  69. Crystal structure of (acetylacetonato-κ2O,O′)-(2-amino-6-chlorobenzoato-κO)-oxido(1,10-phenanthroline-κ2N,N′)vanadium(IV) – trichloromethane (1/1)
  70. Crystal structure of (1E,4E)-1,5-bis(4-chlorophenyl)penta-1,4-dien-3-one, C17H12Cl2O
  71. The crystal structure of trans-dibromido-bis(pyridine-κN)platinum(II), C10H10Br2N2Pt
Heruntergeladen am 25.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0174/html?lang=de
Button zum nach oben scrollen